This research showed a 3× higher in vivo tumor uptake 24 h post injection (p.i.)and a 2.5× lower kidney uptake 4 h p.i. of the folate ligand with albumin binding domain compared to [177Lu]Lu -EC0800, the same folate ligand without albumin binding domain. This evidence concerns the gene ALB and neoplasm.